Health CarePharmaceuticals and Biotechnology
  • Price (JPY)3,280.00
  • Today's Change15.00 / 0.46%
  • Shares traded635.10k
  • 1 Year change+14.45%
  • Beta0.7715
Data delayed at least 20 minutes, as of Dec 03 2021 06:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.

  • Revenue in JPY (TTM)338.32bn
  • Net income in JPY42.45bn
  • Incorporated1949
  • Employees5.42k
  • Location
    Kyowa Kirin Co LtdOtemachi Financial City Grand Cube1-9-2, Ote-machiCHIYODA-KU 100-0004JapanJPN
  • Phone+81 352057200
  • Fax+81 352057182
  • Websitehttps://www.kyowakirin.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Alfresa Holdings Corporation2.60tn20.39bn370.39bn12.05k16.360.678411.340.142696.3496.3412,268.252,323.201.9516.264.34215,587,300.001.532.643.857.256.847.330.78511.321.07--0.000327.87-3.530.2069-39.16-6.875.049.94
ROHTO PHARMACEUTICAL CO., LTD.189.30bn21.32bn386.74bn6.60k17.572.2413.622.04186.37186.371,654.741,459.500.7952.374.1828,699,510.008.986.1312.618.7558.3559.4711.306.961.64--0.079122.70-3.741.658.6512.9716.856.96
Medipal Holdings Corp3.27tn30.52bn498.83bn12.97k14.960.79689.090.1527136.35136.3514,639.422,560.321.9319.674.65251,788,700.002.402.636.517.426.627.131.241.331.06--0.04425.33-1.291.18-36.98-4.91-16.418.45
Sumitomo Dainippon Pharma Co Ltd548.18bn55.37bn539.55bn6.82k9.730.92527.960.9843139.37139.371,379.801,465.690.43751.653.4880,355,320.002.914.404.246.4773.7474.836.658.841.37--0.294222.776.885.0537.9517.882.109.24
Santen Pharmaceutical Co Ltd259.46bn7.32bn573.77bn4.23k78.641.7923.822.2118.2218.22648.27799.130.61742.523.1061,352,330.001.716.082.067.3160.9361.262.7810.212.2722.590.119444.963.335.03-71.10-33.7221.232.29
Nippon Shinyaku Co., Ltd.135.64bn29.19bn577.47bn2.06k18.973.1717.784.26433.39433.392,013.812,592.210.70551.423.5265,874,700.0015.199.6317.5211.4163.4755.5821.5314.214.25--0.0030.434.507.6822.7426.704.9328.73
ONO PHARMACEUTICAL CO., LTD.332.89bn81.87bn1.37tn3.61k15.761.9113.844.10163.99163.99666.821,350.360.44992.363.9192,289,160.0011.089.1812.5510.5873.1572.8424.6221.012.92--0.01339.255.7714.0526.3324.737.586.79
Kyowa Kirin Co Ltd338.32bn42.45bn1.77tn5.42k41.532.4728.015.2478.9778.97629.421,327.480.41311.553.8562,385,580.005.185.635.756.3574.6168.9512.5512.984.96--0.025745.264.10-2.6624.839.5711.8811.97
Eisai Co., Ltd691.25bn62.51bn2.06tn11.24k31.852.7320.422.98218.03218.032,411.122,546.930.63221.963.8761,515,620.005.756.267.618.3676.6470.879.1010.501.71--0.106469.26-7.143.35-65.41-5.17-0.98131.30
Daiichi Sankyo Co Ltd1.01tn86.76bn5.54tn16.03k63.184.1638.335.4745.0545.05525.26684.620.48321.743.8363,139,
Data as of Dec 03 2021. Currency figures normalised to Kyowa Kirin Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

13.01%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 29 Oct 202119.75m3.66%
Daiwa Asset Management Co. Ltd.as of 29 Oct 20219.45m1.75%
Nikko Asset Management Co., Ltd.as of 05 Nov 20218.84m1.64%
Massachusetts Financial Services Co.as of 29 Oct 20216.89m1.28%
The Vanguard Group, Inc.as of 05 Nov 20216.26m1.16%
BlackRock Fund Advisorsas of 04 Nov 20214.84m0.90%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 04 Nov 20214.55m0.84%
Norges Bank Investment Managementas of 31 Dec 20203.95m0.73%
JPMorgan Asset Management (UK) Ltd.as of 04 Nov 20213.69m0.68%
Goldman Sachs Asset Management Co., Ltd. (Japan)as of 30 Sep 20212.03m0.38%
More ▼
Data from 31 Dec 2020 - 30 Sep 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.